CLINICAL_TRIALS
trial_result
· 2023-12-20
Clinical Trial Update: To Evaluate the Immunogenicity and Safety of Two Different Immunization Schedules of Rabies Vaccine (Vero Cell) [Phase 3]
Summary
Phase 3 trial assessing two rabies vaccine immunization schedules; study completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hualan Biological Bacterin Co. Ltd. | Conditions: Rabies Human | Phase 3 | Status: COMPLETED